Evidence map›Paper›PMID 25497478›Full record

ArticleParticle and fibre toxicology2014

Nanometer-long Ge-imogolite nanotubes cause sustained lung inflammation and fibrosis in rats.

Sybille van den Brule, Emilie Beckers, Perrine Chaurand, Wei Liu, Saloua Ibouraadaten, Mihaly Palmai-Pallag, Francine Uwambayinema, Yousof Yakoub, Astrid Avellan, Clément Levard and 5 more

Abstract readComparative Study
In one paragraph

Article in Particle and fibre toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Nanoparticles for cancer therapy: a review of influencing factors and evaluation methods for biosafety.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  3. In Vitro and In Vivo Models to Assess the Immune-Related Effects of Nanomaterials.International journal of environmental research and public health · 2021
    Review
  4. Review
  5. LiCoOParticle and fibre toxicology · 2020
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sybille van den BruleLouvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Avenue E. Mounier 52 - bte B1.52.12, 1200, Brussels, Belgium. sybille.vandenbrule@uclouvain.be.
Emilie BeckersLouvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Avenue E. Mounier 52 - bte B1.52.12, 1200, Brussels, Belgium. beckers.emilie@gmail.com.
Perrine ChaurandCEREGE, Aix Marseille Université, CNRS, IRD, UM34, UMR 7330, Europole de l'arbois - BP 80, 13545, Aix en Provence, France. chaurand@cerege.fr.
Wei LiuCEREGE, Aix Marseille Université, CNRS, IRD, UM34, UMR 7330, Europole de l'arbois - BP 80, 13545, Aix en Provence, France. liu@cerege.fr.
Saloua IbouraadatenLouvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Avenue E. Mounier 52 - bte B1.52.12, 1200, Brussels, Belgium. saloua.ibouraadaten@uclouvain.be.
Mihaly Palmai-PallagLouvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Avenue E. Mounier 52 - bte B1.52.12, 1200, Brussels, Belgium. mihaly.palmai@uclouvain.be.
Francine UwambayinemaLouvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Avenue E. Mounier 52 - bte B1.52.12, 1200, Brussels, Belgium. francine.uwambayinema@uclouvain.be.
Yousof YakoubLouvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Avenue E. Mounier 52 - bte B1.52.12, 1200, Brussels, Belgium. yousof.yakoub@uclouvain.be.
Astrid AvellanCEREGE, Aix Marseille Université, CNRS, IRD, UM34, UMR 7330, Europole de l'arbois - BP 80, 13545, Aix en Provence, France. avellan@cerege.fr.
Clément LevardCEREGE, Aix Marseille Université, CNRS, IRD, UM34, UMR 7330, Europole de l'arbois - BP 80, 13545, Aix en Provence, France. levard@cerege.fr.
Vincent HaufroidLouvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Avenue E. Mounier 52 - bte B1.52.12, 1200, Brussels, Belgium. vincent.haufroid@uclouvain.be.
Etienne MarbaixDe Duve Institute, Université catholique de Louvain, Avenue Hippocrate 75 - bte B1.75.02, 1200, Brussels, Belgium. etienne.marbaix@uclouvain.be.
Antoine ThillLaboratoire Interdisciplinaire sur l'Organisation Nanométrique et Supramoléculaire, CEA Saclay, 91191, Gif sur Yvette, France. antoine.thill@cea.fr.
Dominique LisonLouvain centre for Toxicology and Applied Pharmacology, Université catholique de Louvain, Avenue E. Mounier 52 - bte B1.52.12, 1200, Brussels, Belgium. dominique.lison@uclouvain.be.
Jérôme RoseCEREGE, Aix Marseille Université, CNRS, IRD, UM34, UMR 7330, Europole de l'arbois - BP 80, 13545, Aix en Provence, France. rose@cerege.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGe-imogolites are short aluminogermanate tubular nanomaterials with attractive prospected industrial applications. In view of their nano-scale dimensions and high aspect ratio, they should be examined for their potential to cause respiratory toxicity. Here, we evaluated the respiratory biopersistence and lung toxicity of 2 samples of nanometer-long Ge-imogolites.

methodsRats were intra-tracheally instilled with single wall (SW, 70 nm length) or double wall (DW, 62 nm length) Ge-imogolites (0.02-2 mg/rat), as well as with crocidolite and the hard metal particles WC-Co, as positive controls. The biopersistence of Ge-imogolites and their localization in the lung were assessed by ICP-MS, X-ray fluorescence, absorption spectroscopy and computed micro-tomography. Acute inflammation and genotoxicity (micronuclei in isolated type II pneumocytes) was assessed 3 d post-exposure; chronic inflammation and fibrosis after 2 m.

resultsCytotoxic and inflammatory responses were shown in bronchoalveolar lavage 3 d after instillation with Ge-imogolites. Sixty days after exposure, a persistent dose-dependent inflammation was still observed. Total lung collagen, reflected by hydroxyproline lung content, was increased after SW and DW Ge-imogolites. Histology revealed lung fibre reorganization and accumulation in granulomas with epithelioid cells and foamy macrophages and thickening of the alveolar walls. Overall, the inflammatory and fibrotic responses induced by SW and DW Ge-imogolites were more severe (on a mass dose basis) than those induced by crocidolite. A persistent fraction of Ge-imogolites (15% of initial dose) was mostly detected as intact structures in rat lungs 2 m after instillation and was localized in fibrotic alveolar areas. In vivo induction of micronuclei was significantly increased 3 d after SW and DW Ge-imogolite instillation at non-inflammatory doses, indicating the contribution of primary genotoxicity.

conclusionsWe showed that nm-long Ge-imogolites persist in the lung and promote genotoxicity, sustained inflammation and fibrosis, indicating that short high aspect ratio nanomaterials should not be considered as innocuous materials. Our data also suggest that Ge-imogolite structure and external surface determine their toxic activity.

Indexed as

Air PollutantsAluminum SilicatesAlveolar Epithelial CellsAnimalsCells, CulturedDose-Response Relationship, DrugFemaleGermaniumInhalation ExposureLungMetal NanoparticlesMicronuclei, Chromosome-DefectiveNanotubesParticle SizePneumoniaPulmonary FibrosisAir PollutantsAluminum SilicatesGermanium

Identifiers

PMID25497478
PMCPMC4276264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.